Best Practices for the Development of PSC-Based Therapies: An Updated Draft

Program Description: This webinar will highlight the ISSCR’s "Best Practices for the Translation of PSC-Based Therapies." This resource is being developed for both academics and industry professionals. It outlines key concepts and principles in a visual format that can be applied globally, serving as an international framework for the development of PSC-based therapies.  

Webinar attendees will gain an overview of this “roadmap”, which includes sections on starting materials; banking; raw/ancillary materials, devices, and equipment; regulatory considerations; drug substance/drug product; preclinical development; and clinical research.  

Organizers:
- Kapil Bharti, PhD, Boston Children's Hospital/Harvard Medical School, USA
- Jacqueline Barry, PhD, Cell and Gene Therapy Catapult, UK

Presenters:
- Ricardo Baptista, PhD, SmartCella, Sweden
- Derek Hei, PhD, Kenai Therapeutics, USA
- Claire Henchcliffe, MD, DPhil, University of California, Irvine, USA
- Deborah Hursh, PhD, Hursh Cell Therapy Consulting, LLC, USA
- Jung-Hyun Kim, PhD, Ajou University, South Korea
- Jeanne Loring, PhD, Aspen Neuroscience, USA
- Tenneille Ludwig, PhD, WiCell Research Institute, USA

Thank you to Our Sponsor

 
 

Previous
Previous

Modeling Human Neural Development and Disease with iPSCs

Next
Next

ISSCR Embryo Models Working Group: Summary of Findings and Recommendations